Stratpharma specialises both in the development and in the licensing and global commercialisation of novel medical devices and pharmaceutical products.


The Stratpharma business model facilitates a streamlined, flexible distribution chain that promotes speed to market for new products and delivers superior value to consumers.


We provide patients and their health care professionals with access to innovative and effective health care solutions that meet their essential needs and requirements.



Our mission at Stratpharma:

To partner with the creators of late stage innovative products (P2–P3) and rapidly commercialise these products, in finished form. Then to simultaneously deliver these products to international markets under a single Global Branding Platform.


Our vision at Stratpharma:

To achieve top 3 ranking by market, with each or our internationally marketed brands through retail and medical channels.


Our values at Stratpharma:

  • We challenge industry structures and “road blocks” that impede the rapid delivery of quality medical devices and pharmaceutical products to patients and healthcare professionals on a global basis.
  • We drive out cost from the value chain so that we can deliver “best value” products to our final customers.
  • We respect and value the cultural diversity and needs of our customers.
  • We demand and expect the highest standards of integrity and professionalism from our staff and our value chain partners.


For more information please visit our product websites:

Strataderm®, scar therapy gel,

Stratamed®, advanced film-forming wound dressing,

Stratacel®, film-forming wound dressing for sensitive skin,

Stratamark®, for the prevention and treatment of stretch marks,

StrataXRT®, for the prevention and treatment of radiation dermatitis,